Individual approach to metastatic colorectal cancer treatment (clinical cases)
Open Access
- 1 December 2023
- journal article
- research article
- Published by Russian Association of Coloproctology in Koloproktologia
- Vol. 22 (4) , 104-112
Abstract
Two patients with metastatic colorectal cancer underwent R0 large bowel resection followed by surgery liver and lungs metastases, retroperitoneal lymph nodes and post-op chemotherapy. The total follow-up period of the first patient was currently 12 years, the recurrence-free period was 5 years. In the second patient, stabilization of the disease was observed for 12 years, and the total follow-up period – 18.5 years. An integrated treatment approach to metastatic CRC with active surgery for removable distant metastases or perioperative use of the most effective drug therapy for potentially resectable metastases can control the disease even with an aggressive course.Keywords
This publication has 10 references indexed in Scilit:
- Prognostic factors in colorectal cancerKoloproktologia, 2021
- Impact of primary colorectal Cancer location on the KRAS status and its prognostic valueBMC Gastroenterology, 2019
- Prognostic indicators lose their value with repeated resection of colorectal liver metastasesEuropean Journal of Surgical Oncology, 2018
- The best strategy for RAS wild-type metastatic colorectal cancer patients in first-line treatment: A classic and Bayesian meta-analysisCritical Reviews in Oncology/Hematology, 2018
- Surgical treatment options following chemotherapy plus cetuximab or bevacizumab in metastatic colorectal cancer—central evaluation of FIRE-3European Journal of Cancer, 2018
- First-line panitumumab plus FOLFOX4 or FOLFIRI in colorectal cancer with multiple or unresectable liver metastases: A randomised, phase II trial (PLANET-TTD)European Journal of Cancer, 2017
- Prognostic Survival Associated With Left-Sided vs Right-Sided Colon CancerJAMA Oncology, 2017
- ESMO consensus guidelines for the management of patients with metastatic colorectal cancerAnnals of Oncology, 2016
- Targeting BRAF mutant metastatic colorectal cancer: clinical implications and emerging therapeutic strategiesTargeted Oncology, 2014
- Survival of Patients With Advanced Colorectal Cancer Improves With the Availability of Fluorouracil-Leucovorin, Irinotecan, and Oxaliplatin in the Course of TreatmentJournal of Clinical Oncology, 2004